About the journal
Biologics: Targets & Therapy is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 4,320 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1177-5475 · 1177-5491
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,320 USD
- Articles in DOAJ
- 541
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.dovepress.com/biologics-targets--therapy-journal
Index listings
- DOAJ · 2009-06-05
- Indexing
- DOAJ
- APC
- 4,320 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
541
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
601
Last recorded publication year
2026
h-index
57
i10-index
332
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2009-06-05
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 82%
- ORCID iDs in current deposits
- 83%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101321511
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
Show all subjects (50)
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Inflammatory Bowel Disease
- Inflammatory Bowel Disease
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Autoimmune and Inflammatory Disorders Research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Autoimmune and Inflammatory Disorders Research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Autoimmune Bullous Skin Diseases
- Autoimmune Bullous Skin Diseases
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Asthma and respiratory diseases
- Microscopic Colitis
- Microscopic Colitis
- Asthma and respiratory diseases
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- Multiple Sclerosis Research Studies
- Chronic Myeloid Leukemia Treatments
- Multiple Sclerosis Research Studies
- Urticaria and Related Conditions
- Urticaria and Related Conditions
- Acute Lymphoblastic Leukemia research
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Acute Lymphoblastic Leukemia research
Keywords (DOAJ)
- autoimmune diseases
- cancer
- biological agents
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ